Solactis Group Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Solactis Group General Information


Manufacturer of a bio-functional ingredient designed to improve colon and digestive functions. The company's product, Galactofructose, reduces transit time in colon, improves digestive discomfort as well as reinforces immune defences in the digestive system, enabling users to get relief from gastric and other stomach pains and discomfort.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Delivery
Primary Office
  • Domaine de Vilvert - Bâtiment 325
  • 78352 Jouy-en-Josas
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Solactis Group Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view Solactis Group’s complete valuation and funding history, request access »

Solactis Group Executive Team (1)

Name Title Board Seat Contact Info
Pascal Ronfard Chief Executive Officer
To view Solactis Group’s complete executive team members history, request access »

Solactis Group Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator Minority 000 0000 000000 0
To view Solactis Group’s complete investors history, request access »